المؤلفون: Llinas-Arias, P, Ensenyat-Mendez, M, Orozco, JIJ, Iniguez-Munoz, S, Valdez, B, Wang, C, Mezger, A, Choi, E, Tran, YZ, Yao, LQ, Bonath, F, Olsen, RA, Ormestad, M, Esteller, M, Lupien, M, Marzese, DM

المصدر: BMC genomic data. 24(1):61

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154020458

المؤلفون: Iñiguez-Muñoz S; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Llinàs-Arias P; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Bedoya-López AF; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, 08017, Barcelona, Spain.; Medica Scientia Innovation Research SL (MEDSIR), 08018, Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, 28670, Madrid, Spain., Roy A; Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Forsberg-Nilsson K; Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; University of Nottingham Biodiscovery Institute, Nottingham, UK., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain. dmarzese@gmail.com.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. dmarzese@gmail.com.

المصدر: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Jun 20; Vol. 81 (1), pp. 274. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/genetics , Mutation*, Humans ; Regulatory Sequences, Nucleic Acid/genetics ; Genome, Human ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Gene Expression Regulation, Neoplastic

المؤلفون: Llinàs-Arias P; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Ensenyat-Mendez M; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Íñiguez-Muñoz S; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Valdez B; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Salomon MP; Keck School of Medicine, USC Research Center for Liver Diseases, University of Southern California, Los Angeles, CA, USA., Matsuba C; Keck School of Medicine, USC Research Center for Liver Diseases, University of Southern California, Los Angeles, CA, USA., Solivellas-Pieras M; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Bedoya-López AF; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Sesé B; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain., Mezger A; Science for Life Laboratory, Solna, 17665, Sweden., Ormestad M; Science for Life Laboratory, Solna, 17665, Sweden., Unzueta F; Advanced Optical Microscopy Facility Scientific and Technological Centres of University of Barcelona, Barcelona, Spain., Strand SH; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Boiko AD; Department of Medicine, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA., Hwang ES; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Cortés J; Pangaea Oncology, Quiron Group, International Breast Cancer Center (IBCC), Barcelona, 08017, Spain.; Medica Scientia Innovation Research SL (MEDSIR), Barcelona, 08018, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, 28670, Spain., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, 28029, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain., Lupien M; Princess Margaret Cancer Centre, Toronto, ON, M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L7, Canada.; Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada., Marzese DM; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, 07120, Spain. diego.marzese@ssib.es.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. diego.marzese@ssib.es.

المصدر: Molecular cancer [Mol Cancer] 2023 Nov 28; Vol. 22 (1), pp. 190. Date of Electronic Publication: 2023 Nov 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Carcinoma, Intraductal, Noninfiltrating*/genetics , Carcinoma, Intraductal, Noninfiltrating*/pathology , Triple Negative Breast Neoplasms*/genetics, Humans ; Female ; Chromatin ; Matrix Metalloproteinase 8/genetics ; Neoplasm Recurrence, Local/genetics ; Multigene Family

المؤلفون: Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands, Palma, Spain., Solivellas-Pieras M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands, Palma, Spain., Llinàs-Arias P; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands, Palma, Spain., Íñiguez-Muñoz S; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands, Palma, Spain., Baker JL; Department of Surgery, David Geffen School of Medicine, University California, Los Angeles., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands, Palma, Spain.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, North Carolina.

المصدر: JAMA network open [JAMA Netw Open] 2023 Oct 02; Vol. 6 (10), pp. e2335821. Date of Electronic Publication: 2023 Oct 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/metabolism , Triple Negative Breast Neoplasms*/pathology , Epigenesis, Genetic*/genetics, Female ; Humans ; Middle Aged ; Black or African American/genetics ; Cross-Sectional Studies ; Hormones ; White/genetics ; Adult ; Aged ; Aged, 80 and over

المؤلفون: Chagani S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., De Macedo MP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carapeto F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Marzese DM; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands, Palma, Balearic Islands, Spain; Saint John's Cancer Institute at Saint John's Health Center, PHS, Santa Monica, California, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Peng W; Department of Biology and Biochemistry, The University of Houston, Houston, Texas, USA., Ong GT; NanoString Technologies, Inc, Seattle, Washington, USA., Warren SE; NanoString Technologies, Inc, Seattle, Washington, USA., Beechem JM; NanoString Technologies, Inc, Seattle, Washington, USA., Hoon DSB; Saint John's Cancer Institute at Saint John's Health Center, PHS, Santa Monica, California, USA., Mills GB; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Tetzlaff MT; Department of Pathology, The University of California at San Francisco, San Francisco, California, USA., Lazar AJ; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kwong LN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies MA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: MDavies@mdanderson.org.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2023 Sep; Vol. 143 (9), pp. 1779-1787.e1. Date of Electronic Publication: 2023 Mar 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: PTEN Phosphohydrolase*/genetics , Melanoma*/genetics , Melanoma*/pathology, Humans ; Proteomics ; Genes, Tumor Suppressor ; RNA

المؤلفون: Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Llinàs-Arias P; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Íñiguez-Muñoz S; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Baker JL; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Salomon MP; Department of Medicine, University of Southern California (USC), Los Angeles, CA, USA., Martí M; Immunology Unit, Department of Cell Biology, Physiology, and Immunology, Institut de Biotecnologia I Biomedicina (IBB), Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.; Biosensing and Bioanalysis Group, Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.; Medical Scientia Innovation Research (MedSIR), Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain. Diego.Marzese@ssib.es.

المصدر: Communications medicine [Commun Med (Lond)] 2023 Jul 10; Vol. 3 (1), pp. 93. Date of Electronic Publication: 2023 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

المؤلفون: Carrier A; Unité de Service et de Recherche USR n°3388 CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC), Toulouse, France.; Cancer Epigenetics Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona, Spain., Desjobert C; Unité de Service et de Recherche USR n°3388 CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC), Toulouse, France., Lobjois V; Institut des Technologies Avancées en Sciences du Vivant - ITAV-USR3505, CNRS, Université de Toulouse, Université Paul Sabatier-UT3, Toulouse, France.; Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, CNRS UMR 5088, Université Paul Sabatier-UT3, Toulouse, France., Rigal L; Institut des Technologies Avancées en Sciences du Vivant - ITAV-USR3505, CNRS, Université de Toulouse, Université Paul Sabatier-UT3, Toulouse, France., Busato F; Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humain, CEA-Institut de Biologie Francois Jacob, Université Paris-Saclay, Evry, France., Tost J; Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humain, CEA-Institut de Biologie Francois Jacob, Université Paris-Saclay, Evry, France., Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Pradines A; Inserm, CNRS, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France.; Laboratoire de Biologie Médicale Oncologique, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Favre G; Inserm, CNRS, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France.; Laboratoire de Biologie Médicale Oncologique, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Lamant L; Laboratoire d'Anatomopathologie, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Lanfrancone L; Department of Experimental Oncology, Instituto Europeo di Oncologia, Via Adamello 16, 20139, Milan, Italy., Etievant C; Unité de Service et de Recherche USR n°3388 CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC), Toulouse, France., Arimondo PB; Unité de Service et de Recherche USR n°3388 CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC), Toulouse, France. paola.arimondo@cnrs.fr.; EpiCBio, Epigenetic Chemical Biology, Department Structural Biology and Chemistry, CNRS UMR N°3523, Institut Pasteur, 28 Rue du Dr Roux, 75015, Paris, France. paola.arimondo@cnrs.fr., Riond J; Unité de Service et de Recherche USR n°3388 CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC), Toulouse, France. joelle.riond@inserm.fr.; Inserm, CNRS, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France. joelle.riond@inserm.fr.

المصدر: Clinical epigenetics [Clin Epigenetics] 2022 Nov 28; Vol. 14 (1), pp. 156. Date of Electronic Publication: 2022 Nov 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BiomedCentral Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/genetics , Lung Neoplasms*/genetics, Humans ; DNA Methylation ; Signal Transduction ; Exons

المؤلفون: Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Le J; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Carretera de Valldemosa 79, -1F, Palma, Spain., Baker JL; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Weidhaas J; Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Klomhaus A; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Carretera de Valldemosa 79, -1F, Palma, Spain. diego.marzese@ssib.es., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.dinome@duke.edu.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2022 Oct; Vol. 29 (10), pp. 6407-6414. Date of Electronic Publication: 2022 Jul 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/surgery, Axilla/pathology ; Epigenesis, Genetic ; Female ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Lymphatic Metastasis/pathology ; Machine Learning ; Neoplasm Staging ; Nomograms ; ROC Curve ; Sentinel Lymph Node Biopsy

المؤلفون: Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Le J; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Baker JL; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Illes Balears, Spain., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.dinome@duke.edu.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2022 Oct; Vol. 29 (10), pp. 6415-6416. Date of Electronic Publication: 2022 Aug 02.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/surgery , Neoadjuvant Therapy*, Axilla ; Female ; Humans ; Neoplasm Staging

المؤلفون: Ensenyat-Mendez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain., Rünger D; Statistics Core, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Le J; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Baker JL; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Weidhaas J; Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain. diego.marzese@ssib.es., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.dinome@duke.edu.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2022 Aug; Vol. 29 (8), pp. 4716-4724. Date of Electronic Publication: 2022 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism , Breast Neoplasms*/surgery, Axilla/pathology ; Epigenesis, Genetic ; Female ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymphatic Metastasis/pathology ; Receptors, Estrogen/metabolism ; Sentinel Lymph Node Biopsy/methods